June 2012 FDA Recall Drug by Watson Laboratories Inc
D-1436-2012 - Impurities/Degradation Products

This Class III drug recall was voluntarily initiated by Watson Laboratories Inc on June 5, 2012 for the product Drug. The FDA reported the reason for recall as impurities/degradation products. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1436-2012

Reason for Recall
Impurities/Degradation Products: High Out-of-specification results were obtained for both known and unknown impurities.
Initiated
06-05-2012
Reported
08-08-2012
Quantity
18,938 cartons

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Watson Laboratories Inc
Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Watson Laboratories, Inc., Corona, CA 92880; Distributed by: Watson Pharma, Inc., Corona, CA 92880.

Batch or Lot Expiration Information

Lot# s: 412572A, 412572B, Exp 11/12